AMPLIPHI BIOSCIENCES
AmpliPhi Biosciences is a biopharmaceutical company focused on the development of an internally generated pipeline of naturally occurring viruses called bacteriophage (phage) for the treatment of bacterial infection. Phage-based therapy provides a unique and proven approach to treating a wide variety of bacterial infections and in particular, drug-resistant strains of bacteria that are commonly found in the hospital setting. We have built a drug development and manufacturing platform designed ... to allow rapid development and production of multiple phage-based therapies. Our plan and success relies on our ability to identify and develop selected phage to eradicate targeted bacterial infections across a wide range of bacterial disease. Initially our phage discovery and development platform will focus efforts in acute and chronic lung, sinus and gastrointestinal (GI) infections. AmpliPhi maintains operations in Richmond, Virginia in the United States, in Colworth Science Park, near London in the United Kingdom, and outside Sydney, NSW, Australia.
AMPLIPHI BIOSCIENCES
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
1989-01-01
Address:
Richmond, Virginia, United States
Country:
United States
Website Url:
http://www.ampliphibio.com
Total Employee:
11+
Status:
Active
Contact:
+118048272524
Email Addresses:
[email protected]
Total Funding:
43.99 M USD
Technology used in webpage:
Domain Not Resolving SPF Font Awesome IPv6 Microsoft Exchange Online Google Office 365 Mail Google Cloud Microsoft Azure DNS YouTube
Similar Organizations
Carisma Therapeutics
Carisma Therapeutics is a biotechnology company developing cellular immunotherapies to treat solid tumors.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Advisors List
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-01-04 | C3J Therapeutics | C3J Therapeutics acquired by AmpliPhi Biosciences | N/A |
| 2016-01-08 | Novolytics | Novolytics acquired by AmpliPhi Biosciences | N/A |
| 2011-01-01 | Biocontrol | Biocontrol acquired by AmpliPhi Biosciences | N/A |
Investors List
ROTH Capital Partners
ROTH Capital Partners investment in Post-IPO Equity - AmpliPhi Biosciences
RA Capital Management
RA Capital Management investment in Post-IPO Equity - AmpliPhi Biosciences
BioScience Managers Limited
BioScience Managers Limited investment in Post-IPO Equity - AmpliPhi Biosciences
Third Security
Third Security investment in Post-IPO Equity - AmpliPhi Biosciences
Venrock
Venrock investment in Venture Round - AmpliPhi Biosciences
Official Site Inspections
http://www.ampliphibio.com
- Host name: 180.114.199.104.bc.googleusercontent.com
- IP address: 104.199.114.180
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "AmpliPhi Biosciences"
AmpliPhi Biosciences - Crunchbase Company Profile
Contact Email [email protected] Phone Number +118048272524 AmpliPhi Biosciences is a biopharmaceutical company focused on the …See details»
AmpliPhi Biosciences - LinkedIn
AmpliPhi Biosciences Biotechnology Research Marina del Rey, California 1,498 followers AmpliPhi Biosciences and C3J Therapeutics complete merger and formation of Armata PharmaceuticalsSee details»
AmpliPhi Biosciences - VentureRadar
Website: http://www.ampliphibio.com/ Biotechnology company dedicated to the development of innovative antibacterial solutions to improve human health through the ...See details»
AmpliPhi Biosciences - Craft
May 9, 2019 San Diego, CA HQ. United States. 3579 Valley Centre Dr # 300. Richmond, VA. United States. Biotech Center, 800 E Leigh St. Brookvale, New South Wales. AustraliaSee details»
AmpliPhi Biosciences Corporation - Seattle, USA - bionity.com
Jun 8, 2015 ampliphibio.com +1 206 623 7612. Share. Xing Linkedin Facebook X E-mail Loading... Bookmark. Bookmark list; Bookmark. AmpliPhi Biosciences Corporation. 601 Union …See details»
Company Ampliphi Biosciences Corp Nyse - MarketScreener.com
May 8, 2019 Ampliphi Biosciences Corp: Company profile, business summary, shareholders, managers, financial ratings, industry, sector and market information | Nyse: | NyseSee details»
AmpliPhi Biosciences - PitchBook
AmpliPhi Biosciences General Information Description. Developer of bacteriophage technology intended to control human diseases. The company is focused on improving human health through the development of novel natural …See details»
AmpliPhi - Overview, News & Similar companies | ZoomInfo.com
Nov 10, 2021 AmpliPhi contact info: Phone number: (858) 800-4869 Website: www.ampliphibio.com What does AmpliPhi do? AmpliPhi Biosciences Corporation, a …See details»
investor.ampliphibio.com - Investor Relations - Investor Ampliphibio
Investor.ampliphibio.com. Ampliphi Biosciences Corp is a biotechnology company committed to the development and commercialization of innovative therapies fo...See details»
AmpliPhi Biosciences - Contacts, Employees, Board Members, …
AmpliPhi Biosciences is focused on developing novel bacteriophage-based therapeutics.See details»
AmpliPhi BioSciences Corporation Announces $13 Million Financing
Mar 11, 2015 AmpliPhi BioSciences Corporation (OTCQB: APHB) is a biotechnology company focused on the development and commercialization of novel bacteriophage-based …See details»
AmpliPhi Biosciences Provides Corporate and Strategic Update
Dec 14, 2017 SAN DIEGO–(BUSINESS WIRE)–AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on the development of …See details»
AmplifyBio - Advanced Therapy CDMO
AmplifyBio is a contract research organization (CRO) and manufacturing organization (CDMO) that connects early R&D, safety assessments, and manufacturing to advance drug development.See details»
AmpliPhi Biosciences and C3J Therapeutics Agree to Merge
Jan 4, 2019 Once filed, the proxy statement will be available free of charge on AmpliPhi’s website at www.ampliphibio.com or by contacting AmpliPhi’s Investor Relations by email at …See details»
AmplifyBio - Crunchbase Company Profile & Funding
AmplifyBio is a biotechnology company that develops next-generation cell and gene therapies. The company's mission is to create pathways for novel treatment advances, cutting-edge …See details»
AmplifyBio - Products, Competitors, Financials, Employees, …
AmplifyBio serves as a contract research organization (CRO) and manufacturing organization (CDMO) that provides services in drug discovery, preclinical studies, safety assessments, and …See details»
AmplifyBio Celebrates 2 Years of Innovative Solutions, Preclinical …
May 25, 2023 WEST JEFFERSON, OH / ACCESSWIRE / May 25, 2023 / AmplifyBio, an organization built from a preclinical CRO, launched out of Battelle in 2021 and dedicated to …See details»
AmplifyBio shutters Bay Area site, lays off Ohio CRO staff
Dec 6, 2024 AmplifyBio is cutting costs, closing its R&D and characterization services site in South San Francisco and laying off employees in its Ohio-based preclinical CRO business, a …See details»
AmplifyBio - Contacts, Employees, Board Members, Advisors
AmplifyBio is a biotechnology company that develops and advances treatments and cures for disease via cutting-edge technology and research.See details»
AmplifyBio Company Profile: Overview and Full News Analysis
News Summary AmplifyBio is a leading advanced therapy CRO and CDMO offering a full range of drug development and manufacturing services . Located in the heart of Central Ohios …See details»